Nykredit A/S’s Collegium Pharmaceutical COLL Stock Holding History

Nykredit A/S’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.1K	Buy	+389	New	+$13.3K	﹤0.01%	1821

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Nykredit A/S's COLL Position: Q2 2026 in Review

Nykredit A/S opened a new position in Collegium Pharmaceutical (COLL) in Q2 2026: 389 shares worth $14.1K. The stake represents ﹤0.01% of the portfolio and ranks #1821 among its holdings.

205 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

Nykredit A/S held 389 shares of Collegium Pharmaceutical worth $14.1K as of Q2 2026.
Collegium Pharmaceutical was a new Nykredit A/S position in Q2 2026.
Collegium Pharmaceutical made up ﹤0.01% of Nykredit A/S's portfolio in Q2 2026, its #1821 holding.
205 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.